The hyperactivation of BCR signaling plays a key role in the pathogenesis of CLL and its progression to DLBCL-type RT, as shown in preclinical studies (Figure 2) [60,71,72,73,74]. This evidence concerns the gene BCR and diffuse large B-cell lymphoma.